Lataa...
Pipeline shield with single antiplatelet therapy in aneurysmal subarachnoid haemorrhage: multicentre experience
BACKGROUND: The Pipeline Embolisation Device with Shield technology (PED-Shield) is suggested to have reduced thrombogenicity. This reduced thrombogenicity may make it possible to use safely in the acute treatment of aneurysmal subarachnoid haemorrhage (aSAH) on single antiplatelet therapy (SAPT). O...
Tallennettuna:
| Julkaisussa: | J Neurointerv Surg |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMJ Publishing Group
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6582735/ https://ncbi.nlm.nih.gov/pubmed/30552166 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/neurintsurg-2018-014363 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|